Aberdeen Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5M Buy
97,128
+2,736
+3% +$141K 0.01% 706
2025
Q1
$5.49M Buy
94,392
+48,730
+107% +$2.84M 0.01% 671
2024
Q4
$3.29M Sell
45,662
-2,380
-5% -$172K 0.01% 709
2024
Q3
$3.8M Buy
48,042
+2,492
+5% +$197K 0.01% 694
2024
Q2
$3.26M Sell
45,550
-19,890
-30% -$1.43M 0.01% 695
2024
Q1
$4.61M Buy
65,440
+127
+0.2% +$8.94K 0.01% 682
2023
Q4
$5.04M Buy
65,313
+26,901
+70% +$2.08M 0.01% 667
2023
Q3
$2.61M Sell
38,412
-1,411
-4% -$96K 0.01% 658
2023
Q2
$3.25M Sell
39,823
-4,456
-10% -$364K 0.01% 646
2023
Q1
$3.29M Sell
44,279
-127
-0.3% -$9.42K 0.01% 651
2022
Q4
$3.68M Sell
44,406
-1,362
-3% -$113K 0.01% 602
2022
Q3
$3.25M Sell
45,768
-8,928
-16% -$634K 0.01% 620
2022
Q2
$4.73M Buy
54,696
+3,616
+7% +$313K 0.01% 557
2022
Q1
$5.61M Sell
51,080
-888
-2% -$97.6K 0.01% 553
2021
Q4
$6.72M Sell
51,968
-2,120
-4% -$274K 0.01% 582
2021
Q3
$6.66M Buy
54,088
+50,652
+1,474% +$6.24M 0.02% 596
2021
Q2
$387K Buy
+3,436
New +$387K ﹤0.01% 957